Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/11251

Title:	Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
Authors:	Machuca, Isabel Gutiérrez-Gutiérrez, Belén Gracia-Ahufinger, Irene Rivera Espinar, Francisco Cano, Ángela Guzmán-Puche, Julia Pérez-Nadales, Elena Natera, Clara Rodríguez, Marina León, Rafael Castón, Juan J Rodríguez-López, Fernando Rodríguez-Baño, Jesús Torre-Cisneros, Julián
Keywords:	Klebsiella pneumoniae;bacteremia;carbapenems;colistin;mortality
metadata.dc.subject.mesh:	Aged Anti-Bacterial Agents Bacteremia Colistin Drug Combinations Drug Resistance, Multiple, Bacterial Female Fosfomycin Gentamicins Humans Klebsiella Infections Klebsiella pneumoniae Male Meropenem Microbial Sensitivity Tests Middle Aged Minocycline Prospective Studies Shock, Septic Thienamycins Tigecycline
Issue Date:	25-Jul-2017
Abstract:	Combination therapy including colistin and a carbapenem has been found to be associated with lower mortality in the treatment of bloodstream infections (BSI) due to KPC-producing Klebsiella pneumoniae when the isolates show a meropenem or imipenem MIC of
URI:	http://hdl.handle.net/10668/11251
metadata.dc.identifier.doi:	10.1128/AAC.00406-17
Appears in Collections:	Producción 2020

Files in This Item:

There are no files associated with this item.

This item is protected by original copyright

Show full item record Recommend this item

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.

RISalud